Clinical Trial Update: The Effect of Entecavir Consolidation on Post-TDF Treatment Durability [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether entecavir consolidation improves durability after discontinuing tenofovir in chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN